Ajit Elhance
Immunology and Microbiology · The Ohio State University
Publications
22
Citations
459
Est. group size
~9
Recurring co-author estimate
Active years
8
Publishing since 2019
This researcher's publication record spans immunology-related cancer biology, particularly the role of immune signaling molecules like IL-33 in tumor progression, as well as more recent work on vascular disease, sepsis, and clinical epidemiology topics. The bibliographic data suggest a research trajectory that includes cellular and molecular mechanisms of cancer alongside broader clinical and translational research questions. Prospective students should note the diversity of topics covered, which may reflect either a research group with multiple concurrent projects or contributions across collaborative studies.
Publication output has varied over the last decade, rising to a peak in 2022 before declining and stabilizing at a lower level in recent years, with an average of 2.8 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Sex differences in aortopathy, arteriopathy, and mortality in vascular Ehlers-Danlos syndrome
Journal of Vascular Surgery · 2026
- Timing matters: a machine learning–driven comparison of community and hospital-onset sepsis
BMC Medical Informatics and Decision Making · 2026
- Association of post-thrombotic syndrome with metabolic syndrome and inflammation - a systematic review
Frontiers in Immunology · 2025
- A mechanistic basis for the malignant progression of salivary gland tumors
iScience · 2021
- Response to Comment on “Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression”
Science · 2021
- Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression
Science · 2020
- ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival
Life Science Alliance · 2019
- Abstract 2033: Bidirectional paracrine IL-33-TGF-beta signaling underlies a tumor-promoting stem cell niche
Cancer Research · 2019
- Abstract 2033: Bidirectional paracrine IL-33-TGF-beta signaling underlies a tumor-promoting stem cell niche
Tumor Biology · 2019
- Science×2
- Frontiers in Immunology×2
- Translational research×1
- Molecular & Cellular Proteomics×1
- Nature Communications×1
- Ashley Zani
Immunology and Microbiology · The Ohio State University
- Jacob S. Yount
Immunology and Microbiology · The Ohio State University
- Adam D. Kenney
Immunology and Microbiology · The Ohio State University
- Tianliang Li
Immunology and Microbiology · The Ohio State University
- Jeffrey Kawahara
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile